These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34121410)

  • 1. Drug Release from Disulfide-Linked Prodrugs: Role of Thiol Agents.
    Lei J; Zhang Q; Jin X; Lu H; Wang S; Li T; Sheng Y; Zhang F; Zheng Y
    Mol Pharm; 2021 Jul; 18(7):2777-2785. PubMed ID: 34121410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
    Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-sensitive lipophilic prodrugs: delivering unstable chemotherapeutant for improved cancer therapy.
    Li F; Huang Z; Chen H; Yan L; Li J; Su Y; Zhang Q; Huang Z; Zheng Y
    Drug Deliv; 2019 Dec; 26(1):1068-1079. PubMed ID: 31735094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H
    Mu X; Huang Z; Feng W; Zhai M; Wang Y; Zhou D; Zhou X
    Theranostics; 2023; 13(1):267-277. PubMed ID: 36593965
    [No Abstract]   [Full Text] [Related]  

  • 6. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing.
    Ao M; Yu F; Li Y; Zhong M; Tang Y; Yang H; Wu X; Zhuang Y; Wang H; Sun X; Hong X; Chen XD
    J Nanobiotechnology; 2021 Oct; 19(1):350. PubMed ID: 34717646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A GSH-Responsive Nanoprodrug System Based on Self-Assembly of Lactose Modified Camptothecin for Targeted Drug Delivery and Combination Chemotherapy.
    Hou C; Ma N; Shen Z; Chi G; Chao S; Pei Y; Chen L; Lu Y; Pei Z
    Int J Nanomedicine; 2020; 15():10417-10424. PubMed ID: 33376329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of glutathione responsive glycosylated camptothecin nanosupramolecular prodrug.
    Li W; Chen Z; Liu X; Lian M; Peng H; Zhang C
    Drug Deliv; 2021 Dec; 28(1):1903-1914. PubMed ID: 34519602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulus-Responsive Nano-Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery.
    Chu B; Deng H; Niu T; Qu Y; Qian Z
    Small Methods; 2024 Aug; 8(8):e2301271. PubMed ID: 38085682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
    He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
    Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.
    Zhang F; Zhu G; Jacobson O; Liu Y; Chen K; Yu G; Ni Q; Fan J; Yang Z; Xu F; Fu X; Wang Z; Ma Y; Niu G; Zhao X; Chen X
    ACS Nano; 2017 Sep; 11(9):8838-8848. PubMed ID: 28858467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ethylene glycol) shell-sheddable nanomicelle prodrug of camptothecin with enhanced cellular uptake.
    Wu Q; Du F; Luo Y; Lu W; Huang J; Yu J; Liu S
    Colloids Surf B Biointerfaces; 2013 May; 105():294-302. PubMed ID: 23384692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
    Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy.
    He W; Du Y; Zhou W; Wang T; Li M; Li X
    Eur J Pharm Sci; 2020 Jul; 150():105340. PubMed ID: 32371069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy.
    He W; Hu X; Jiang W; Liu R; Zhang D; Zhang J; Li Z; Luan Y
    Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29076266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
    Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
    J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computer-aided, heterodimer-based "triadic" carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency.
    Yang L; Zhang Y; Lai Y; Xu W; Lei S; Chen G; Wang Z
    J Colloid Interface Sci; 2025 Jan; 677(Pt B):523-540. PubMed ID: 39154445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
    Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
    J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.